{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:27:01Z","timestamp":1787164021867,"version":"build-2736575974"},"reference-count":275,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01223","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T01:14:00Z","timestamp":1593652440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?"],"prefix":"10.3389","volume":"11","author":[{"given":"Hui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Catalfamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nat Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/ni.2392","volume":"13","author":"Pardoll","year":"2012","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19851","DOI":"10.1073\/pnas.0810032105","article-title":"HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells","volume":"105","author":"Catalfamo","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cytogfr.2012.05.007","article-title":"The role of cytokines in the pathogenesis and treatment of HIV infection","volume":"23","author":"Catalfamo","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.4049\/jimmunol.173.4.2410","article-title":"CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection","volume":"173","author":"Doisne","year":"2004","journal-title":"J Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/COH.0b013e3283454c39","article-title":"Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control","volume":"6","author":"Hersperger","year":"2011","journal-title":"Curr Opin HIV AIDS."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1084\/jem.20061496","article-title":"PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection","volume":"203","author":"Petrovas","year":"2006","journal-title":"J Exp Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1182\/blood-2007-01-069112","article-title":"SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection","volume":"110","author":"Petrovas","year":"2007","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1182\/blood-2006-09-044826","article-title":"PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors","volume":"109","author":"Zhang","year":"2007","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/ni1515","article-title":"Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction","volume":"8","author":"Kaufmann","year":"2007","journal-title":"Nat Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.2232","article-title":"Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BAT","volume":"16","author":"Quigley","year":"2010","journal-title":"Nat Med F."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1002840","DOI":"10.1371\/journal.ppat.1002840","article-title":"CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction","volume":"8","author":"Peretz","year":"2012","journal-title":"PLoS Pathog."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1172\/JCI60612","article-title":"PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques","volume":"122","author":"Dyavar Shetty","year":"2012","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/infdis\/jis630","article-title":"Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells","volume":"208","author":"Hatano","year":"2013","journal-title":"J Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/QAD.0000000000000314","article-title":"Programmed death-1 expression on CD4(+) and CD8(+) T cells in treated and untreated HIV disease","volume":"28","author":"Cockerham","year":"2014","journal-title":"AIDS."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.4049\/jimmunol.1402176","article-title":"The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects","volume":"194","author":"Tian","year":"2015","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/infdis\/jiv226","article-title":"Elevated expression of CD160 and 2B4 defines a cytolytic HIV-specific CD8+ T-cell population in elite controllers","volume":"212","author":"Pombo","year":"2015","journal-title":"J Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1005349","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT marks exhausted t cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection","volume":"12","author":"Chew","year":"2016","journal-title":"PLoS Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1005761","DOI":"10.1371\/journal.ppat.1005761","article-title":"CD4+ Tcells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART","volume":"12","author":"Fromentin","year":"2016","journal-title":"PLoS Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1172\/jci.insight.122940","article-title":"Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV","volume":"3","author":"Mylvaganam","year":"2018","journal-title":"JCI Insight."},{"key":"B25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science."},{"key":"B28","doi-asserted-by":"publisher","first-page":"10187","DOI":"10.1128\/JVI.75.21.10187-10199.2001","article-title":"Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment","volume":"75","author":"Lifson","year":"2001","journal-title":"J Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J Exp Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/QAD.0b013e328353bcaf","volume":"26","author":"McDermott","year":"2012","journal-title":"AIDS"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood."},{"key":"B32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ni.3161","article-title":"Success and failure of the cellular immune response against HIV-1","volume":"16","author":"Migueles","year":"2015","journal-title":"Nat Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1586\/erv.10.132","article-title":"Cytolytic CD4(+) T cells in viral immunity","volume":"9","author":"Soghoian","year":"2010","journal-title":"Expert Rev Vaccines."},{"key":"B34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/COH.0000000000000094","article-title":"Distinctive features of CD4+ T cell dysfunction in chronic viral infections","volume":"9","author":"Morou","year":"2014","journal-title":"Curr Opin HIV AIDS."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1097\/QAD.0000000000001223","article-title":"C.group, CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection","volume":"30","author":"Buggert","year":"2016","journal-title":"AIDS."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/v10060336","article-title":"Harnessing Tfollicular helper cell responses for HIV vaccine development","volume":"10","author":"Niessl","year":"2018","journal-title":"Viruses."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1006973","DOI":"10.1371\/journal.ppat.1006973","article-title":"Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease","volume":"14","author":"Buggert","year":"2018","journal-title":"PLoS Pathog."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41590-019-0418-x","article-title":"Altered differentiation is central to HIV-specific CD4(+) T cell dysfunction in progressive disease","volume":"20","author":"Morou","year":"2019","journal-title":"Nat Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2015.5","article-title":"HIV reservoirs: what, where and how to target them","volume":"14","author":"Churchill","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/intimm\/10.10.1563","article-title":"Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses","volume":"10","author":"Nishimura","year":"1998","journal-title":"Int Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.immuni.2012.03.024","article-title":"Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1","volume":"36","author":"Hirahara","year":"2012","journal-title":"Immunity."},{"key":"B44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.immuni.2007.05.016","article-title":"Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses","volume":"27","author":"Butte","year":"2007","journal-title":"Immunity."},{"key":"B45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1073\/pnas.0931259100","article-title":"PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells","volume":"100","author":"Loke","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B49","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0006-291X(03)01257-9","article-title":"Differential binding properties of B7-H1 and B7-DC to programmed death-1","volume":"307","author":"Youngnak","year":"2003","journal-title":"Biochem Biophys Res Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/intimm\/dxq049","article-title":"PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1","volume":"22","author":"Ghiotto","year":"2010","journal-title":"Int Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.molimm.2011.06.436","article-title":"PD-L2 is expressed on activated human T cells and regulates their function","volume":"48","author":"Messal","year":"2011","journal-title":"Mol Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1002\/eji.200526347","article-title":"PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion","volume":"35","author":"Saunders","year":"2005","journal-title":"Eur J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine","volume":"98","author":"Okazaki","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B54","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.celrep.2018.03.026","article-title":"SHP-2 Is dispensable for establishing T cell exhaustion and for PD-1 signaling in vivo","volume":"23","author":"Rota","year":"2018","journal-title":"Cell Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1016\/j.celrep.2019.05.041","article-title":"Quantitative interactomics in primary T cells provides a rationale for concomitant PD-1 and BTLA coinhibitor blockade in cancer immunotherapy","volume":"27","author":"Celis-Gutierrez","year":"2019","journal-title":"Cell Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.febslet.2004.07.083","article-title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70\/CD3zeta signalosome and downstream signaling to PKCtheta","volume":"574","author":"Sheppard","year":"2004","journal-title":"FEBS Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","article-title":"SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation","volume":"173","author":"Chemnitz","year":"2004","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"ra46","DOI":"10.1126\/scisignal.2002796","article-title":"Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation","volume":"5","author":"Patsoukis","year":"2012","journal-title":"Sci Signal."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J Exp Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.4161\/cc.22135","article-title":"PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25","volume":"11","author":"Patsoukis","year":"2012","journal-title":"Cell Cycle."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science."},{"key":"B65","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.2496","article-title":"The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood","volume":"14","author":"Sage","year":"2013","journal-title":"Nat Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/imr.12411","article-title":"T follicular regulatory cells","volume":"271","author":"Sage","year":"2016","journal-title":"Immunol Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","article-title":"PD-1 controls follicular T helper cell positioning and function","volume":"49","author":"Shi","year":"2018","journal-title":"Immunity."},{"key":"B69","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature."},{"key":"B71","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity."},{"key":"B72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","article-title":"Molecular and transcriptional basis of CD4(+) T cell dysfunction during chronic infection","volume":"40","author":"Crawford","year":"2014","journal-title":"Immunity."},{"key":"B73","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 Tcell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature."},{"key":"B76","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity."},{"key":"B77","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining 'T cell exhaustion'","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.4049\/jimmunol.1200646","article-title":"Programmed death-1 is a marker for abnormal distribution of naive\/memory T cell subsets in HIV-1 infection","volume":"191","author":"Breton","year":"2013","journal-title":"J Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e0193829","DOI":"10.1371\/journal.pone.0193829","article-title":"Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection","volume":"13","author":"Rallon","year":"2018","journal-title":"PLoS ONE."},{"key":"B81","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/QAI.0b013e3181fbab9f","article-title":"Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatment","volume":"56","author":"Grabmeier-Pfistershammer","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1371\/journal.pmed.0050100","article-title":"Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells","volume":"5","author":"Streeck","year":"2008","journal-title":"PLoS Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"Perreau","year":"2013","journal-title":"J Exp Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers","volume":"21","author":"Fukazawa","year":"2015","journal-title":"Nat Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1126\/sciimmunol.aar4526","article-title":"Identification and characterization of HIV-specific resident memory CD8(+) T cells in human lymphoid tissue","volume":"3","author":"Buggert","year":"2018","journal-title":"Sci Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/COH.0000000000000523","article-title":"Everything in its right place: resident memory CD8+ T cell immunosurveillance of HIV infection","volume":"14","author":"Buggert","year":"2019","journal-title":"Curr Opin HIV AIDS."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/nm.2934","article-title":"Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines","volume":"18","author":"Fukazawa","year":"2012","journal-title":"Nat Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.4049\/jimmunol.178.11.6975","article-title":"CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue","volume":"178","author":"Connick","year":"2007","journal-title":"J Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/scitranslmed.aag2285","article-title":"Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies","volume":"9","author":"Petrovas","year":"2017","journal-title":"Sci Transl Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1073\/pnas.1621418114","article-title":"Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection","volume":"114","author":"Mylvaganam","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1172\/JCI96207","article-title":"Accumulation of follicular CD8+ T cells in pathogenic SIV infection","volume":"128","author":"Ferrando-Martinez","year":"2018","journal-title":"J Clin Invest."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3389\/fimmu.2018.01095","article-title":"Differentiation and function of follicular CD8 T cells during human immunodeficiency virus infection","volume":"9","author":"Xiao","year":"2018","journal-title":"Front Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.3389\/fimmu.2018.02950","article-title":"Editorial: lymph node T cell dynamics and novel strategies for HIV cure","volume":"9","author":"Petrovas","year":"2018","journal-title":"Front Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/ni.3589","article-title":"Programs for the persistence, vigilance and control of human CD8(+) lung-resident memory T cells","volume":"17","author":"Hombrink","year":"2016","journal-title":"Nat Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.it.2016.11.004","article-title":"Transcriptional regulation of tissue-resident lymphocytes","volume":"38","author":"Mackay","year":"2017","journal-title":"Trends Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat Commun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.smim.2008.06.001","article-title":"The lymph node in HIV pathogenesis","volume":"20","author":"Lederman","year":"2008","journal-title":"Semin Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1172\/JCI0214789","article-title":"Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection","volume":"109","author":"Altfeld","year":"2002","journal-title":"J Clin Invest."},{"key":"B100","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory pathways in the B7-CD28 ligand-receptor family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","article-title":"Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade","volume":"170","author":"Wei","year":"2017","journal-title":"Cell."},{"key":"B102","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1365-2567.2008.02822.x","article-title":"TcR-induced regulated secretion leads to surface expression of CTLA-4 in CD4+CD25+ T cells","volume":"125","author":"Catalfamo","year":"2008","journal-title":"Immunology."},{"key":"B103","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.immuni.2006.08.024","article-title":"T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor","volume":"25","author":"Valk","year":"2006","journal-title":"Immunity."},{"key":"B104","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1074-7613(00)80480-X","article-title":"Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement","volume":"4","author":"Linsley","year":"1996","journal-title":"Immunity."},{"key":"B105","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-065X.2009.00770.x","article-title":"CD28 and CTLA-4 coreceptor expression and signal transduction","volume":"229","author":"Rudd","year":"2009","journal-title":"Immunol Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1128\/MCB.01331-13","article-title":"Rab8 binding to immune cell-specific adaptor LAX facilitates formation of trans-Golgi network-proximal CTLA-4 vesicles for surface expression","volume":"34","author":"Banton","year":"2014","journal-title":"Mol Cell Biol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1126\/science.272.5265.1170","article-title":"Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4","volume":"272","author":"Marengere","year":"1996","journal-title":"Science."},{"key":"B108","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1074-7613(00)00031-5","article-title":"The CD28 and CTLA-4 receptors associate with the serine\/threonine phosphatase PP2A","volume":"13","author":"Chuang","year":"2000","journal-title":"Immunity."},{"key":"B109","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4049\/jimmunol.164.1.5","article-title":"Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4","volume":"164","author":"Cinek","year":"2000","journal-title":"J Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4049\/jimmunol.164.1.49","article-title":"The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation","volume":"164","author":"Baroja","year":"2000","journal-title":"J Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.it.2014.12.001","article-title":"Confusing signals: recent progress in CTLA-4 biology","volume":"36","author":"Walker","year":"2015","journal-title":"Trends Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.00806.x","article-title":"Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection","volume":"115","author":"Steiner","year":"1999","journal-title":"Clin Exp Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00002030-200203080-00002","article-title":"CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention","volume":"16","author":"Leng","year":"2002","journal-title":"AIDS."},{"key":"B114","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.1128\/JVI.00249-06","article-title":"Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection","volume":"80","author":"Zaunders","year":"2006","journal-title":"J Virol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.4049\/jimmunol.0803771","article-title":"PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention","volume":"182","author":"Kaufmann","year":"2009","journal-title":"J Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.4049\/jimmunol.1000156","article-title":"Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection","volume":"185","author":"Kassu","year":"2010","journal-title":"J Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1128\/JVI.01263-17","article-title":"Differential inhibitory receptor expression on T cells delineates functional capacities in chronic viral infection","volume":"91","author":"Teigler","year":"2017","journal-title":"J Virol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2018.00019","article-title":"Human immunodeficiency virus type-1 elite controllers maintain low co-expression of inhibitory receptors on CD4+ T cells","volume":"9","author":"Noyan","year":"2018","journal-title":"Front Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3389\/fimmu.2018.00734","article-title":"Regulatory T Cells as potential targets for HIV cure research","volume":"9","author":"Kleinman","year":"2018","journal-title":"Front Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/infdis\/jis238","article-title":"Regulatory T cells in HIV-1 infection: the good, the bad, and the ugly","volume":"205","author":"Imamichi","year":"2012","journal-title":"J Infect Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fimmu.2016.00192","article-title":"Functional mechanisms of treg in the context of HIV infection and the janus face of immune suppression","volume":"7","author":"Lopez-Abente","year":"2016","journal-title":"Front Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fimmu.2012.00178","article-title":"Multiple treg suppressive modules and their adaptability","volume":"3","author":"Wing","year":"2012","journal-title":"Front Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"11593","DOI":"10.1128\/JVI.00760-07","article-title":"Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection","volume":"81","author":"Boasso","year":"2007","journal-title":"J Virol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.4049\/jimmunol.0902955","article-title":"Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control","volume":"184","author":"Nigam","year":"2010","journal-title":"J Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.4049\/jimmunol.174.6.3143","article-title":"The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients","volume":"174","author":"Andersson","year":"2005","journal-title":"J Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity."},{"key":"B127","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity."},{"key":"B128","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1073\/pnas.94.11.5744","article-title":"Characterization of the major histocompatibility complex class II binding site on LAG-3 protein","volume":"94","author":"Huard","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3389\/fimmu.2018.01909","article-title":"Not all immune checkpoints are created equal","volume":"9","author":"De Sousa","year":"2018","journal-title":"Front Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/intimm\/11.11.1745","article-title":"The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes","volume":"11","author":"Hannier","year":"1999","journal-title":"Int Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1096\/fasebj.10.7.8635694","article-title":"Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-gamma production","volume":"10","author":"Annunziato","year":"1996","journal-title":"FASEB J."},{"key":"B132","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.4049\/jimmunol.161.8.4058","article-title":"CD3\/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3\/TCR signaling","volume":"161","author":"Hannier","year":"1998","journal-title":"J Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A","article-title":"Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)","volume":"32","author":"Workman","year":"2002","journal-title":"Eur J Immunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1158\/0008-5472.CAN-13-2690","article-title":"LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1158\/2326-6066.CIR-14-0150","article-title":"Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells","volume":"3","author":"Kouo","year":"2015","journal-title":"Cancer Immunol Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell."},{"key":"B137","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.4049\/jimmunol.169.10.5392","article-title":"Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3","volume":"169","author":"Workman","year":"2002","journal-title":"J Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.4049\/jimmunol.173.11.6806","article-title":"Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)","volume":"173","author":"Li","year":"2004","journal-title":"J Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"e1005661","DOI":"10.1371\/journal.ppat.1005661","article-title":"Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection","volume":"12","author":"Hoffmann","year":"2016","journal-title":"PLoS Pathog."},{"key":"B140","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1038\/ncomms9495","article-title":"Immunological biomarkers predict HIV-1 viral rebound after treatment interruption","volume":"6","author":"Hurst","year":"2015","journal-title":"Nat Commun."},{"key":"B141","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1172\/JCI40115","article-title":"Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys","volume":"119","author":"Bosinger","year":"2009","journal-title":"J Clin Invest."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.4049\/jimmunol.0803222","article-title":"Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection","volume":"183","author":"Li","year":"2009","journal-title":"J Immunol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1172\/JCI45235","article-title":"Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque","volume":"121","author":"Rotger","year":"2011","journal-title":"J Clin Invest."},{"key":"B144","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12977-015-0142-z","article-title":"Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment","volume":"12","author":"Juno","year":"2015","journal-title":"Retrovirology."},{"key":"B145","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2016.04.007","article-title":"CD4+ T-cell gene expression of healthy donors, HIV-1 and elite controllers: immunological chaos","volume":"83","author":"Nunnari","year":"2016","journal-title":"Cytokine."},{"key":"B146","doi-asserted-by":"publisher","first-page":"e0206256","DOI":"10.1371\/journal.pone.0206256","article-title":"Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells","volume":"13","author":"Pallikkuth","year":"2018","journal-title":"PLoS ONE."},{"key":"B147","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1182\/blood-2010-11-317297","article-title":"Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection","volume":"117","author":"Yamamoto","year":"2011","journal-title":"Blood."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e1007429","DOI":"10.1371\/journal.ppat.1007429","article-title":"Roles, function and relevance of LAG3 in HIV infection","volume":"15","author":"Graydon","year":"2019","journal-title":"PLoS Pathog."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1089\/aid.2014.0356","article-title":"Increased frequency of CD49b\/LAG-3(+) type 1 regulatory T cells in HIV-infected individuals","volume":"31","author":"Koch","year":"2015","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B150","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jim.2018.02.003","article-title":"Establishment of engineered cell-based assays mediating LAG3 and PD1 immune suppression enables potency measurement of blocking antibodies and assessment of signal transduction","volume":"456","author":"Bhagwat","year":"2018","journal-title":"J Immunol Methods"},{"key":"B151","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"17858","DOI":"10.1073\/pnas.0903474106","article-title":"The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity","volume":"106","author":"Stanietsky","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B153","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/eji.200839116","article-title":"A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC","volume":"39","author":"Boles","year":"2009","journal-title":"Eur J Immunol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"40354","DOI":"10.1038\/srep40354","article-title":"Perturbed CD8(+) T cell TIGIT\/CD226\/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals","volume":"7","author":"Tauriainen","year":"2017","journal-title":"Sci Rep."},{"key":"B155","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/cdd.2012.141","article-title":"Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells","volume":"20","author":"Liu","year":"2013","journal-title":"Cell Death Differ."},{"key":"B156","doi-asserted-by":"publisher","first-page":"17647","DOI":"10.1074\/jbc.M114.572420","article-title":"T-cell immunoglobulin and ITIM domain (TIGIT) receptor\/poliovirus receptor (PVR) ligand engagement suppresses interferon-gamma production of natural killer cells via beta-arrestin 2-mediated negative signaling","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4049\/jimmunol.1003081","article-title":"Cutting edge: TIGIT has T cell-intrinsic inhibitory functions","volume":"186","author":"Joller","year":"2011","journal-title":"J Immunol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/QAI.0000000000002001","article-title":"PD-1+ and TIGIT+ CD4 T cells are associated with coronary artery calcium progression in HIV-infected treated adults","volume":"81","author":"Bowler","year":"2019","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B159","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3389\/fimmu.2018.02783","article-title":"Multivariate computational analysis of gamma delta T cell inhibitory receptor signatures reveals the divergence of healthy and ART-Suppressed HIV+ aging","volume":"9","author":"Belkina","year":"2018","journal-title":"Front Immunol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.3389\/fimmu.2018.02341","article-title":"Expression of the inhibitory receptor TIGIT is up-regulated specifically on NK cells with CD226 activating receptor from HIV-infected individuals","volume":"9","author":"Yin","year":"2018","journal-title":"Front Immunol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3389\/fimmu.2018.02233","article-title":"Lymph node cellular dynamics in cancer and HIV: what can we learn for the follicular CD4 (Tfh) cells?","volume":"9","author":"Poultsidi","year":"2018","journal-title":"Front Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni988","article-title":"Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance","volume":"4","author":"Sabatos","year":"2003","journal-title":"Nat Immunol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1002\/eji.200939274","article-title":"TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines","volume":"39","author":"Hastings","year":"2009","journal-title":"Eur J Immunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol Rev."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.1148536","article-title":"Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells","volume":"318","author":"Anderson","year":"2007","journal-title":"Science."},{"key":"B168","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat Immunol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.4049\/jimmunol.0903059","article-title":"T cell\/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells","volume":"184","author":"DeKruyff","year":"2010","journal-title":"J Immunol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat Immunol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/blood-2008-10-185884","article-title":"Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation","volume":"113","author":"Nakayama","year":"2009","journal-title":"Blood."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.2871","article-title":"Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion","volume":"18","author":"Rangachari","year":"2012","journal-title":"Nat Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1128\/MCB.05297-11","article-title":"Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways","volume":"31","author":"Lee","year":"2011","journal-title":"Mol Cell Biol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbrc.2006.10.079","article-title":"A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9","volume":"351","author":"van de Weyer","year":"2006","journal-title":"Biochem Biophys Res Commun."},{"key":"B176","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4049\/jimmunol.1302663","article-title":"T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases","volume":"192","author":"Clayton","year":"2014","journal-title":"J Immunol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"e106442","DOI":"10.1371\/journal.pone.0106442","article-title":"A regulatory polymorphism in HAVCR2 modulates susceptibility to HIV-1 infection","volume":"9","author":"Sironi","year":"2014","journal-title":"PLoS ONE."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"Jones","year":"2008","journal-title":"J Exp Med."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/aid.2010.0156","article-title":"Suppression of HIV replication by antiretroviral therapy reduces TIM-3 expression on HIV-specific CD8(+) T cells","volume":"27","author":"Kassu","year":"2011","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B180","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/QAD.0000000000000589","article-title":"Up-regulation of Tim-3 on T cells during acute simian immunodeficiency virus infection and on antigen specific responders","volume":"29","author":"Amancha","year":"2015","journal-title":"AIDS."},{"key":"B181","doi-asserted-by":"publisher","first-page":"916936","DOI":"10.1155\/2015\/916936","article-title":"Elevation of Tim-3 and PD-1 expression on T cells appears early in HIV infection, and differential Tim-3 and PD-1 expression patterns can be induced by common gamma -chain cytokines","volume":"2015","author":"Zhang","year":"2015","journal-title":"Biomed Res Int."},{"key":"B182","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.4049\/jimmunol.1400961","article-title":"Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques","volume":"193","author":"Fujita","year":"2014","journal-title":"J Immunol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B184","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.clim.2017.09.002","article-title":"Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade","volume":"183","author":"Grabmeier-Pfistershammer","year":"2017","journal-title":"Clin Immunol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"e40146","DOI":"10.1371\/journal.pone.0040146","article-title":"Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection","volume":"7","author":"Sakhdari","year":"2012","journal-title":"PLoS ONE."},{"key":"B186","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1084\/jem.20082429","article-title":"TIMs: central regulators of immune responses","volume":"205","author":"Hafler","year":"2008","journal-title":"J Exp Med."},{"key":"B187","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1084\/jem.188.1.83","article-title":"Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines","volume":"188","author":"Chun","year":"1998","journal-title":"J Exp Med."},{"key":"B188","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature."},{"key":"B189","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1073\/pnas.1609057113","article-title":"Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy","volume":"113","author":"Imamichi","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B190","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat Med."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science."},{"key":"B193","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1038\/s41467-019-10884-9","article-title":"Determinants of HIV-1 reservoir size and long-term dynamics during suppressive AR","volume":"10","author":"Bachmann","year":"2019","journal-title":"Nat Commun."},{"key":"B194","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the latent reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity."},{"key":"B195","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41590-018-0242-8","article-title":"Strategies for an HIV cure: progress and challenges","volume":"19","author":"Wang","year":"2018","journal-title":"Nat Immunol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature."},{"key":"B198","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ebiom.2019.04.011","article-title":"HIV \u201ccure\u201d: A shot in the arm?","volume":"42","author":"Peluso","year":"2019","journal-title":"EBioMedicine."},{"key":"B199","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1172\/JCI126714","article-title":"HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy","volume":"130","author":"McManus","year":"2019","journal-title":"J Clin Invest."},{"key":"B200","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1172\/JCI64314","article-title":"Expansion of HIV-specific T follicular helper cells in chronic HIV infection","volume":"122","author":"Lindqvist","year":"2012","journal-title":"J Clin Invest."},{"key":"B201","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1172\/JCI63039","article-title":"CD4 T follicular helper cell dynamics during SIV infection","volume":"122","author":"Petrovas","year":"2012","journal-title":"J Clin Invest."},{"key":"B202","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4049\/jimmunol.166.1.690","article-title":"Persistence of infectious HIV on follicular dendritic cells","volume":"166","author":"Smith","year":"2001","journal-title":"J Immunol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat Med."},{"key":"B204","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat Med."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1099\/vir.0.000065","article-title":"Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation","volume":"96","author":"El-Far","year":"2015","journal-title":"J Gen Virol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/QAD.0000000000001849","article-title":"Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency","volume":"32","author":"Evans","year":"2018","journal-title":"AIDS."},{"key":"B207","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41467-019-08798-7","article-title":"PD-1 blockade potentiates HIV latency reversal ex vivo in CD4(+) T cells from ART-suppressed individuals","volume":"10","author":"Fromentin","year":"2019","journal-title":"Nat Commun."},{"key":"B208","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41591-018-0017-7","article-title":"Clonal CD4(+) T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation","volume":"24","author":"Cohn","year":"2018","journal-title":"Nat Med."},{"key":"B209","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.immuni.2017.09.018","article-title":"CTLA-4(+)PD-1(-) memory CD4(+) T cells critically contribute to viral persistence in antiretroviral therapy-suppressed, SIV-infected rhesus macaques","volume":"47","author":"McGary","year":"2017","journal-title":"Immunity."},{"key":"B210","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1128\/JVI.01344-18","article-title":"Bone marrow-derived CD4(+) T cells are depleted in simian immunodeficiency virus-infected macaques and contribute to the size of the replication-competent reservoir","volume":"93","author":"Hoang","year":"2019","journal-title":"J Virol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3389\/fimmu.2018.02339","article-title":"Targeting immune checkpoint molecules to eliminate latent HIV","volume":"9","author":"Boyer","year":"2018","journal-title":"Front Immunol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"e0211112","DOI":"10.1371\/journal.pone.0211112","article-title":"Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART","volume":"14","author":"Bui","year":"2019","journal-title":"PLoS ONE."},{"key":"B213","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-specific immunity in vivo by PD-1 blockade","volume":"458","author":"Velu","year":"2009","journal-title":"Nature."},{"key":"B214","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1172\/JCI43271","article-title":"Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques","volume":"120","author":"Titanji","year":"2010","journal-title":"J Clin Invest."},{"key":"B215","doi-asserted-by":"publisher","first-page":"980","DOI":"10.4049\/jimmunol.182.2.980","article-title":"PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination","volume":"182","author":"Finnefrock","year":"2009","journal-title":"J Immunol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1128\/AAC.01163-19","article-title":"PD-1 blockade and TLR7 activation lack therapeutic benefit in chronic simian immunodeficiency virus-infected macaques on antiretroviral therapy","volume":"63","author":"Bekerman","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B217","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41591-020-0782-y","article-title":"CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption","volume":"26","author":"Harper","year":"2020","journal-title":"Nat Med."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamaoncol.2019.2244","article-title":"Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer-A phase 1 study","volume":"5","author":"Uldrick","year":"2019","journal-title":"JAMA Oncol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/QAD.0000000000001429","article-title":"Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab","volume":"31","author":"Le Garff","year":"2017","journal-title":"AIDS."},{"key":"B220","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/annonc\/mdx696","article-title":"Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer","volume":"29","author":"Guihot","year":"2018","journal-title":"Ann Oncol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/annonc\/mdy259","article-title":"Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection","volume":"29","author":"Scully","year":"2018","journal-title":"Ann Oncol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1097\/QAD.0000000000001217","article-title":"Programed death-1\/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab)","volume":"30","author":"Gill","year":"2016","journal-title":"AIDS."},{"key":"B223","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/infdis\/jiz485","article-title":"Recombinant human interleukin-15 and anti-PD-L1 combination therapy expands a CXCR3+PD1-\/low CD8 T-cell subset in simian immunodeficiency virus-infected rhesus macaques","volume":"221","author":"Chen","year":"2020","journal-title":"J Infect Dis."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/infdis\/jix191","article-title":"Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy","volume":"215","author":"Gay","year":"2017","journal-title":"J Infect Dis."},{"key":"B225","article-title":"Viral suppression was induced by anti-PD-L1 following ARV-interruption in SIV-infected monkeys","volume-title":"21st Conference on Retroviruses Opportunistic Infections.","author":"Mason","year":"2014"},{"key":"B226","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fimmu.2014.00199","article-title":"Regulatory T cells diminish HIV infection in dendritic cells - conventional CD4(+) T cell clusters","volume":"5","author":"Moreno-Fernandez","year":"2014","journal-title":"Front Immunol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1182\/blood-2006-04-010637","article-title":"CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques","volume":"108","author":"Hryniewicz","year":"2006","journal-title":"Blood."},{"key":"B228","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.4049\/jimmunol.180.8.5439","article-title":"Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection","volume":"180","author":"Cecchinato","year":"2008","journal-title":"J Immunol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/QAD.0000000000000562","article-title":"Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma","volume":"29","author":"Wightman","year":"2015","journal-title":"AIDS."},{"key":"B230","doi-asserted-by":"publisher","first-page":"e0198158","DOI":"10.1371\/journal.pone.0198158","article-title":"An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients","volume":"13","author":"Colston","year":"2018","journal-title":"PLoS ONE."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.4049\/jimmunol.1901191","article-title":"Combination immune checkpoint blockade to reverse HIV latency","volume":"204","author":"Van der Sluis","year":"2020","journal-title":"J Immunol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1128\/JVI.01715-09","article-title":"Gut mucosal FOXP3+ regulatory CD4+ T cells and nonregulatory CD4+ T cells are differentially affected by simian immunodeficiency virus infection in rhesus macaques","volume":"84","author":"Allers","year":"2010","journal-title":"J Virol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.virol.2017.12.036","article-title":"Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins","volume":"516","author":"Zhang","year":"2018","journal-title":"Virology."},{"key":"B234","doi-asserted-by":"publisher","first-page":"e3305","DOI":"10.1371\/journal.pone.0003305","article-title":"Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy","volume":"3","author":"Tran","year":"2008","journal-title":"PLoS ONE."},{"key":"B235","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-4690-10-31","article-title":"Molecular signatures of T-cell inhibition in HIV-1 infection","volume":"10","author":"Larsson","year":"2013","journal-title":"Retrovirology."},{"key":"B236","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nri1901","article-title":"Nat Rev Immunol","volume":"6","author":"Waldmann","year":"2006"},{"key":"B237","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1073\/pnas.092675799","article-title":"IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B238","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1158\/0008-5472.CAN-15-1498","article-title":"IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy","volume":"75","author":"Pilipow","year":"2015","journal-title":"Cancer Res."},{"key":"B239","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1182\/blood-2008-12-189266","article-title":"Safety and immunologic effects of IL-15 administration in nonhuman primates","volume":"114","author":"Berger","year":"2009","journal-title":"Blood."},{"key":"B240","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1182\/blood-2011-09-377804","article-title":"IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood","volume":"118","author":"Sneller","year":"2011","journal-title":"Blood."},{"key":"B241","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1182\/blood-2010-10-311456","article-title":"Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques","volume":"117","author":"Waldmann","year":"2011","journal-title":"Blood."},{"key":"B242","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood-2011-05-351155","article-title":"IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques","volume":"118","author":"Lugli","year":"2011","journal-title":"Blood."},{"key":"B243","doi-asserted-by":"publisher","first-page":"e200465","DOI":"10.1001\/jamaoncol.2020.046","article-title":"Assessment of the feasibility and safety of durvalumab for treatment of solid tumors in patients with HIV-1 infection: the phase 2 DURVAST study","volume":"9","author":"Gonzalez-Cao","year":"2020","journal-title":"JAMA Oncol."},{"key":"B244","article-title":"PD-1 and CTLA-4 blockade in macaques induces t-cell expansion and siv reactivation","author":"Justin","year":"2019","journal-title":"Conference on Retroviruses and Opportunistic Infections. Seattle, Washington DC"},{"key":"B245","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41467-020-14670-w","article-title":"Immune checkpoint modulation enhances HIV-1 antibody induction","volume":"11","author":"Bradley","year":"2020","journal-title":"Nat Commun."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jamaoncol.2018.6737","article-title":"Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: a systematic review","volume":"5","author":"Cook","year":"2019","journal-title":"JAMA Oncol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/annonc\/mdx817","article-title":"PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?","volume":"29","author":"Lavole","year":"2018","journal-title":"Ann Oncol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"e1007619","DOI":"10.1371\/journal.ppat.1007619","article-title":"Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection","volume":"15","author":"Pardons","year":"2019","journal-title":"PLoS Pathog."},{"key":"B249","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1200\/JCO.2005.03.4413","article-title":"Elevated incidence of lung cancer among HIV-infected individuals","volume":"24","author":"Engels","year":"2006","journal-title":"J Clin Oncol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","article-title":"Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges","volume":"28","author":"Rubinstein","year":"2014","journal-title":"AIDS."},{"key":"B251","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/COH.0000000000000327","article-title":"Evolving epidemiology of HIV-associated malignancies","volume":"12","author":"Shiels","year":"2017","journal-title":"Curr Opin HIV AIDS."},{"key":"B252","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40425-019-0618-9","article-title":"Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer","volume":"7","author":"Adashek","year":"2019","journal-title":"J Immunother Cancer."},{"key":"B253","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1016\/S2352-3018(18)30179-6","article-title":"Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study","volume":"5","author":"Hessol","year":"2018","journal-title":"Lancet HIV."},{"key":"B254","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin Infect Dis."},{"key":"B255","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet."},{"key":"B256","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2468-2667(16)30020-2","article-title":"Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort","volume":"2","author":"Croxford","year":"2017","journal-title":"Lancet Public Health."},{"key":"B257","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-981-10-5765-6_10","article-title":"Malignancies in HIV-Infected and AIDS patients","volume":"1018","author":"Ji","year":"2017","journal-title":"Adv Exp Med Biol."},{"key":"B258","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol."},{"key":"B259","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States","volume":"32","author":"Suneja","year":"2014","journal-title":"J Clin Oncol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/cncr.30642","article-title":"Immune checkpoint inhibitors in challenging populations","volume":"123","author":"Johnson","year":"2017","journal-title":"Cancer."},{"key":"B261","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1200\/JCO.2017.73.7338","article-title":"Modernizing clinical trial eligibility criteria: recommendations of the American society of clinical oncology-friends of cancer research HIV working group","volume":"35","author":"Uldrick","year":"2017","journal-title":"J Clin Oncol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s12094-018-1981-6","article-title":"Cancer immunotherapy of patients with HIV infection","volume":"21","author":"Gonzalez-Cao","year":"2019","journal-title":"Clin Transl Oncol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/COH.0000000000000321","article-title":"Cancer clinical trials in persons with HIV infection","volume":"12","author":"Little","year":"2017","journal-title":"Curr Opin HIV AIDS."},{"key":"B264","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jtho.2018.03.031","article-title":"Safety and efficacy of PD-1 inhibitors among HIV-positive patients with non-small cell lung cancer","volume":"13","author":"Ostios-Garcia","year":"2018","journal-title":"J Thorac Oncol."},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0379-x","article-title":"Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection","author":"Husnain","year":"2018","journal-title":"J Immunother Cancer."},{"key":"B266","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3389\/fimmu.2019.02060","article-title":"Immunotherapy in people with HIV and cancer","volume":"10","author":"Puronen","year":"2019","journal-title":"Front Immunol."},{"key":"B267","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/annonc\/mdx538","article-title":"Checkpoint blockade for metastatic melanoma and merkel cell carcinoma in HIV-positive patients","volume":"28","author":"Heppt","year":"2017","journal-title":"Ann Oncol."},{"key":"B268","doi-asserted-by":"publisher","first-page":"970","DOI":"10.12688\/f1000research.17401.1","article-title":"Recent advances in HIV-associated Kaposi sarcoma","volume":"8","author":"Dalla Pria","year":"2019","journal-title":"F1000Res."},{"key":"B269","doi-asserted-by":"publisher","first-page":"2989048","DOI":"10.1155\/2019\/7921582","article-title":"Outcomes of programmed cell death protein 1 (PD-1) and programmed death-ligand 1(PD-L1) inhibitor therapy in HIV patients with advanced cancer","volume":"2019","author":"Bari","year":"2019","journal-title":"J Oncol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1097\/QAD.0000000000002298","article-title":"Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience","volume":"33","author":"Spano","year":"2019","journal-title":"AIDS."},{"key":"B271","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.6004\/jnccn.2018.7064","article-title":"Evolving paradigms in HIV malignancies: review of ongoing clinical trials","volume":"16","author":"Bender Ignacio","year":"2018","journal-title":"J Natl Compr Canc Netw."},{"key":"B272","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1158\/2326-6066.CIR-18-0121","article-title":"Successful treatment of HIV-associated kaposi sarcoma with immune checkpoint blockade","volume":"6","author":"Galanina","year":"2018","journal-title":"Cancer Immunol Res."},{"key":"B273","doi-asserted-by":"publisher","first-page":"e1914816","DOI":"10.1001\/jamanetworkopen.2019.14816","article-title":"Characteristics of immune checkpoint inhibitors trials associated with inclusion of patients with HIV: a systematic review and meta-analysis","volume":"2","author":"Sorotsky","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B274","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamaoncol.2019.2206","article-title":"Quality assessment of a systematic review for HIV infection and advanced-stage cancer-in reply","volume":"5","author":"Cook","year":"2019","journal-title":"JAMA Oncol"},{"key":"B275","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/QAD.0000000000002397","article-title":"Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?","volume":"34","author":"Abbar","year":"2020","journal-title":"AIDS."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T04:54:03Z","timestamp":1696308843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":275,"alternative-id":["10.3389\/fimmu.2020.01223"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01223","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"article-number":"1223"}}